Company: ADPT
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001193125-25-103752
Chunk: 55

Company: Adaptive Biotechnologies Corp
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 55
---
 vacation programs. Dr. Benzeno is also party to the Form of Executive Non-Disclosureand Assignment Agreement. We are also party to an executive severance agreement which details potential benefits and payments on termination or change in control. Chief Scientific Officer – Harlan Robins, PhD We are party to an amended and restated employment agreement with Dr. Robins, pursuant to which we employ him on an at-willbasis. Under the agreement, Dr. Robins is eligible to participate in our broad-based benefit plans, including group health insurance and vacation programs. Dr. Robins is also party to the Form of Executive Non-Disclosureand Assignment Agreement. We are also party to an executive severance agreement which details potential benefits and payments on termination or change in control. President and Chief Operating Officer – Julie Rubinstein We are party to an amended and restated employment agreement with Ms. Rubinstein, pursuant to which we employ her on an at-willbasis. Under the agreement, Ms. Rubinstein is eligible to participate in our broad-based benefit plans, including group health insurance and vacation programs. Ms. Rubinstein is also party to the Form of Executive Non-Disclosureand Assignment Agreement. We are also party to an executive severance agreement which details potential benefits and payments on termination or change in control. Potential Benefits and Payments on Termination or Change in Control Termination Benefits Under the Form Severance Agreement Under our form of executive severance agreement (“Form Severance Agreement”), if an executive officer’s employment is terminated by us without Cause (as defined in the Form Severance Agreement) or the executive officer voluntarily resigns for Good Reason (as defined in the Form Severance Agreement), then, subject to the executive officer’s continued compliance with the obligations set forth in the executive officer’s nondisclosure and assignment agreement and the executive officer’s signing and not revoking a separation agreement and release of claims, the executive officer is entitled to:

| • |     | a lump sum payment equal to 12 months base salary for Mr. Robins, and 6 months base salary for Mr. Piskel, Dr. Benzeno, Dr. Robins and Ms. Rubinstein, as in effect on their effective termination date; |

| • |     | 12 months of COBRA continuation premiums for Mr. Robins, and 6 months of COBRA continuation premiums for Mr. Piskel, Dr. Benzeno, Dr. Robins and Ms. Rubinstein; and |

| • |